Complement-Mediated Macrophage Polarization in Perivascular Adipose Tissue Contributes to Vascular Injury in Deoxycorticosterone Acetate-Salt Mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 3, 2015, Pages 598-606

  Ruan, Cheng Chao ^a   Ge, Qian ^a   Li, Yan ^a   Li, Xiao Dong ^a   Chen, Dong Rui ^a   Ji, Kai Da ^a   Wu, Yong Jie ^a   Sheng, Li Juan ^a   Yan, Chen ^b   Zhu, Ding Liang ^a   Gao, Ping Jin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

complement; macrophage polarization; perivascular adipose tissue; vascular injury

Indexed keywords

BIOCHEMICAL MARKER; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5A; DEOXYCORTICOSTERONE ACETATE; GAMMA INTERFERON; INOSINATE DEHYDROGENASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STAT6 PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; C3 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE;

ADIPOSE TISSUE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; BONE MARROW TRANSPLANTATION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; HYPERTENSION; MACROPHAGE; MACROPHAGE ACTIVATION; MESENTERIC ARTERY; MOUSE; NONHUMAN; PERIVASCULAR SPACE; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; VASCULAR REMODELING; 3T3 CELL LINE; ADIPOCYTE; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PERITONEUM MACROPHAGE; SIGNAL TRANSDUCTION; TIME FACTOR; VASCULAR DISEASES;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BONE MARROW TRANSPLANTATION; CELL COMMUNICATION; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C5A; DESOXYCORTICOSTERONE ACETATE; DISEASE MODELS, ANIMAL; HYPERTENSION; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR DISEASES; VASCULAR REMODELING;

EID: 84922235080     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304927     Document Type: Article

References (29)

1. Thalmann S, Meier CA, Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res 2007 75 690 701. doi: 10.1016/j.cardiores.2007.03.008
2. Brown NK, Zhou Z, Zhang J, Zeng R, Wu J, Eitzman DT, Chen YE, Chang L, Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol 2014 34 1621 1630. doi: 10.1161/ATVBAHA.114.303029
3. Omar A, Chatterjee TK, Tang Y, Hui DY, Weintraub NL, Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol 2014 34 1631 1636. doi: 10.1161/ATVBAHA.114.303030
4. Ruan CC, Zhu DL, Chen QZ, Chen J, Guo SJ, Li XD, Gao PJ, Perivascular adipose tissue-derived complement 3 is required for adventitial fibroblast functions and adventitial remodeling in deoxycorticosterone acetate-salt hypertensive rats. Arterioscler Thromb Vasc Biol 2010 30 2568 2574. doi: 10.1161/ATVBAHA.110.215525
5. Ricklin D, Hajishengallis G, Yang K, Lambris JD, Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010 11 785 797. doi: 10.1038/ni.1923
6. Zipfel PF, Skerka C, Complement regulators and inhibitory proteins. Nat Rev Immunol 2009 9 729 740. doi: 10.1038/nri2620
7. Dunkelberger JR, Song WC, Complement and its role in innate and adaptive immune responses. Cell Res 2010 20 34 50. doi: 10.1038/cr.2009.139
8. Markiewski MM, Lambris JD, The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007 171 715 727. doi: 10.2353/ajpath.2007.070166
9. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, Rudich S, Weintraub NL, Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 2009 104 541 549. doi: 10.1161/CIRCRESAHA.108.182998
10. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM, Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009 119 1661 1670. doi: 10.1161/CIRCULATIONAHA.108.821181
11. Withers SB, Agabiti-Rosei C, Livingstone DM, Little MC, Aslam R, Malik RA, Heagerty AM, Macrophage activation is responsible for loss of anticontractile function in inflamed perivascular fat. Arterioscler Thromb Vasc Biol 2011 31 908 913. doi: 10.1161/ATVBAHA.110.221705
12. Biswas SK, Mantovani A, Orchestration of metabolism by macrophages. Cell Metab 2012 15 432 437. doi: 10.1016/j.cmet.2011.11.013
13. Sica A, Mantovani A, Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012 122 787 795. doi: 10.1172/JCI59643
14. Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V, Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis. Arterioscler Thromb Vasc Biol 2011 31 2856 2864. doi: 10.1161/ATVBAHA.111.237198
15. Zhuang G, Meng C, Guo X, Cheruku PS, Shi L, Xu H, Li H, Wang G, Evans AR, Safe S, Wu C, Zhou B, A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012 125 2892 2903. doi: 10.1161/CIRCULATIONAHA.111.087817
16. Guo RF, Ward PA, Role of C5a in inflammatory responses. Annu Rev Immunol 2005 23 821 852. doi: 10.1146/annurev.immunol.23.021704.115835
17. Phieler J, Chung KJ, Chatzigeorgiou A, Klotzsche-von Ameln A, Garcia-Martin R, Sprott D, Moisidou M, Tzanavari T, Ludwig B, Baraban E, Ehrhart-Bornstein M, Bornstein SR, Mziaut H, Solimena M, Karalis KP, Economopoulou M, Lambris JD, Chavakis T, The complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance. J Immunol 2013 191 4367 4374. doi: 10.4049/jimmunol.1300038
18. Spence S, Fitzsimons A, Boyd CR, Kessler J, Fitzgerald D, Elliott J, Gabhann JN, Smith S, Sica A, Hams E, Saunders SP, Jefferies CA, Fallon PG, McAuley DF, Kissenpfennig A, Johnston JA, Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity 2012 38 66 78. doi: 10.1016/j.immuni.2012.09.013
19. Hanna RN, Shaked I, Hubbeling HG, Punt JA, Wu R, Herrley E, Zaugg C, Pei H, Geissmann F, Ley K, Hedrick CC, NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res 2012 110 416 427. doi: 10.1161/CIRCRESAHA.111.253377
20. Bakker EN, Pistea A, Spaan JA, Rolf T, de Vries CJ, van Rooijen N, Candi E, VanBavel E, Flow-dependent remodeling of small arteries in mice deficient for tissue-type transglutaminase: possible compensation by macrophage-derived factor XIII. Circ Res 2006 99 86 92. doi: 10.1161/01.RES.0000229657.83816.a7
21. Shagdarsuren E, Wellner M, Braesen JH, Park JK, Fiebeler A, Henke N, Dechend R, Gratze P, Luft FC, Muller DN, Complement activation in angiotensin II-induced organ damage. Circ Res 2005 97 716 724. doi: 10.1161/01.RES.0000182677.89816.38
22. Onat A, Can G, Rezvani R, Cianflone K, Complement C3 and cleavage products in cardiometabolic risk. Clin Chim Acta 2011 412 1171 1179. doi: 10.1016/j.cca.2011.03.005
23. Mogilenko DA, Kudriavtsev IV, Trulioff AS, Shavva VS, Dizhe EB, Missyul BV, Zhakhov AV, Ischenko AM, Perevozchikov AP, Orlov SV, Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages. J Biol Chem 2012 287 5954 5968. doi: 10.1074/jbc.M111.289322
24. Wenzel P, Knorr M, Kossmann S, Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 2011 124 1370 1381. doi: 10.1161/CIRCULATIONAHA.111.034470
25. De Ciuceis C, Amiri F, Brassard P, Endemann DH, Touyz RM, Schiffrin EL, Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. Arterioscler Thromb Vasc Biol 2005 25 2106 2113. doi: 10.1161/01.ATV.0000181743.28028.57
26. Lee YC, Chang HH, Chiang CL, Liu CH, Yeh JI, Chen MF, Chen PY, Kuo JS, Lee TJ, Role of perivascular adipose tissue-derived methyl palmitate in vascular tone regulation and pathogenesis of hypertension. Circulation 2011 124 1160 1171. doi: 10.1161/CIRCULATIONAHA.111.027375
27. Han Y, Fukuda N, Ueno T, Endo M, Ikeda K, Xueli Z, Matsumoto T, Soma M, Matsumoto K, Role of complement 3a in the synthetic phenotype and angiotensin II-production in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens 2012 25 284 289. doi: 10.1038/ajh.2011.214
28. Asgari E, Le Friec G, Yamamoto H, Perucha E, Sacks SS, Köhl J, Cook HT, Kemper C, C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. Blood 2013 122 3473 3481. doi: 10.1182/blood-2013-05-502229
29. Zhang C, Li Y, Wang C, Wu Y, Cui W, Miwa T, Sato S, Li H, Song WC, Du J, Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling. Arterioscler Thromb Vasc Biol 2014 34 1240 1248. doi: 10.1161/ATVBAHA.113.303120